Thymalin — Dosing & Research | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Thymalin

Also known as: Thymaline, Thymic factor, Thymus polypeptide extract, Cytomedins (thymalin), Thymic hormone preparation

Polypeptide complex / thymic peptide immunomodulator (derived from bovine/cattle thymus extract)

Research chemicalLast updated: October 19, 2026Based on 33 peer-reviewed studies

What it is

Thymalin is a thymic peptide preparation used in Russia for immune modulation, infectious disease, and aging-related immune decline. It works by supporting the immune system's regulatory functions, including T-cell activity. Not FDA-approved; approved and used clinically in Russia; most evidence comes from Russian clinical trials with limited independent replication.

The scientific side

Thymalin is a polypeptide complex isolated from the thymus gland that regulates immune system function. Its active dipeptide components include KE (which stimulates cellular immunity and activates macrophages, lymphocytes, thymocytes, and neutrophils) and EW (which reduces angiotensin-induced vasoconstriction and inhibits ACE2, the target protein of SARS-CoV-2). Thymalin stimulates differentiation of hematopoietic stem cells (HSC), reducing expression of CD44 and CD117 (stem cell markers) by 2–3 times while increasing CD28 expression (marker of mature T lymphocytes) by 6.8 times, thereby promoting maturation of CD117+ cells into CD28+ T lymphocytes. It normalizes LDH isoenzyme spectra and cyclase systems in lymphocytes, and promotes expression of differentiation antigens on T-lymphocyte surfaces, restoring functional T-lymphocyte activity. In the context of COVID-19, Thymalin and its dipeptide components EW and KE reduce synthesis of pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in human peripheral blood mononuclear cells by 1.4–6.0 times, with potential targets including AKT1, AKT2, ACE2, CYSLTR1, and CHUK genes involved in cytokine storm pathogenesis. In bone healing, thymalin injection activates reparative osteogenesis by reducing neutrophil leukocytes, increasing monocytes, macrophages, lymphocytes, and fibroblastic differon cells, and modulating osteoblast and osteoclast activity. Thymalin also modulates hemostasis, normalizing blood coagulation, fibrinolysis, and fibrinogen levels (PMID 6546722, PMID 3488603).

Class: Polypeptide complex / thymic peptide immunomodulator (derived from bovine/cattle thymus extract)

Administration & storage

Administration
Intramuscular injection — referenced in ophthalmic herpes study (PMID: 1763455)Subcutaneous injection — referenced in ophthalmic herpes study (PMID: 1763455)Intraosseous (intraosteal) lavage — reported in pediatric odontogenic osteomyelitis (PMID: 2326818)Intralymphatic (endolymphatic) administration — reported in appendicular peritonitis (PMID: 3754913)Soft tissue injection (perilesionalsurrounding bone defect) — reported in mandibular bone defect rat model (PMID: 38431810)
Storage
No abstracts in the reviewed literature address storage conditions for Thymalin.
Cautions
No formal pharmacokinetic (PK) data in humans were reported in the reviewed abstracts — the absorption, distribution, metabolism, and elimination profile of Thymalin is not established from the reviewed literature.,Thymalin is described as a polypeptide extract from cattle (bovine) thymus; risk of biological contaminants or batch-to-batch variability inherent to animal-derived extracts should be considered.,The majority of human clinical data in the reviewed abstracts are observational or non-randomized comparative studies from the 1980s–1990s, limiting the strength of safety conclusions.,Use with heparin was specifically noted to be indicated for elderly patients and those at higher thromboformation risk — co-administration with anticoagulants warrants caution and clinical supervision.,Sterile technique is essential for all injection routes reported (intramuscular, subcutaneous, intraosseous, intralymphatic, soft tissue).

Legal & regulatory status

US FDA

Not stated in reviewed literature — requires manual verification

WADA

Not stated in reviewed literature — requires manual verification

Health Canada

Not stated in reviewed literature — requires manual verification